• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Samsung Launches Upgraded Sleep Apnea Detection on Galaxy Ring and Watch: First FDA-Cleared Smart Ring Metric

by Jasmine Pennic 11/03/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Samsung Launches Upgraded Sleep Apnea Detection on Galaxy Ring and Watch: First FDA-Cleared Smart Ring Metric

What You Should Know

  • Samsung Electronics America officially announced that its upgraded Sleep Apnea feature is now available across the United States on both the Galaxy Ring and compatible Galaxy Watch devices.
  • The commercial rollout follows 510(k) clearance from the U.S. Food and Drug Administration (FDA) received in July 2026, alongside recent regulatory approval from South Korea’s Ministry of Food and Drug Safety (MFDS).
  • The milestone marks the world’s first FDA-cleared over-the-counter (OTC) sleep apnea risk-detection software designed specifically for a smart ring form factor.
  • Operating via the Samsung Health Monitor app, the updated feature transitions from basic risk categorization to actively calculating the estimated number of breathing disruptions detected per hour of sleep.

From Binary Alerts to Hourly Disruption Quantities

Samsung initially secured FDA De Novo authorization in February 2024 for the first wearable-based detection of moderate-to-severe OSA on the Galaxy Watch series. However, that first-generation iteration served primarily as a binary notification engine, simply indicating whether retrospective physiological patterns suggested risk.

The upgraded 2026 release transitions from passive alerts to structured physiological quantification:

  • Quantified Breathing Disruptions per Hour: Beyond providing a high-level risk score, the updated algorithm continuously analyzes peripheral blood oxygen saturation (SpO2) dynamics, photoplethysmography (PPG) pulse waveforms, and tri-axial accelerometer movement signals during sleep to calculate an estimated number of breathing disruptions detected per hour.
  • Low-Burden Screening Protocol: The feature requires a low data-capture threshold, requiring only two nights of valid tracking data within a rolling 10-day monitoring window.
  • Clinical Discussion Scaffolding: By quantifying hourly disruptions inside the Samsung Health Monitor application, the feature equips adult consumers (ages 18 and older) with structured objective trend logs that can be directly exported to primary care physicians, pulmonologists, and sleep specialists for confirmatory PSG diagnostic orders.
  • Device Availability & Software Dependencies: The upgraded capability is available immediately on the newly released Galaxy Watch9 running Wear OS 7.0 or higher and the Galaxy Ring, with scheduled firmware updates slated to extend the feature to Galaxy Watch7 and Galaxy Watch8 models.

Jongmin Choi, Head of Health R&D Group, Mobile eXperience (MX) Business at Samsung Electronics, framed the public health intent: “Samsung has long worked to make sleep health a simple and seamless part of everyday life. This approval from Korea’s MFDS, along with our introduction of the world’s first FDA cleared over-the-counter smart ring, reflects our commitment to accessible innovation. We are giving people the tools to help spot possible early signs of sleep apnea and take charge of their wellbeing.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Samsung

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Redesign Health Study: 71% of Health Systems Adopt an "Epic-First" AI Purchasing Strategy

Redesign Health Study: 71% of Health Systems Adopt an “Epic-First” AI Purchasing Strategy

iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

M&A: iRhythm to Acquire VitalConnect for $287.5M to Build Broad Cardiac Intelligence Platform

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

CB Insights Q2 2026 State of Digital Health Report: Fewest Deals in Over a Decade as Median Sizes Rise

mount-sinai-launches-epic-chart-with-art-nursing-ambient-ai

Mount Sinai Medical Center Extends Epic’s Ambient AI to Inpatient Nursing

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

M&A: Tempus AI to Acquire Personalis for $1.5B to Expand Precision Oncology and MRD Monitoring

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |